neuroendocrine tumors

You have access
Triple-Peptide Receptor Targeting In Vitro Allows Detection of All Tested Gut and Bronchial NETs
Jean Claude Reubi and Beatrice Waser

Journal of Nuclear Medicine April 1, 2015, 56 (4) 613-615; DOI: https://doi.org/10.2967/jnumed.114.153189
You have access
Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using ¹⁷⁷Lu-DOTATATE
Ezgi Ilan, Mattias Sandström, Cecilia Wassberg, Anders Sundin, Ulrike Garske–Román, Barbro Eriksson, Dan Granberg and Mark Lubberink

Journal of Nuclear Medicine February 1, 2015, 56 (2) 177-182; DOI: https://doi.org/10.2967/jnumed.114.148437
You have access
In Vivo Biodistribution of No-Carrier-Added 6-¹⁸F-Fluoro-3,4-Dihydroxy-l-Phenylalanine (¹⁸F-DOPA), Produced by a New Nucleophilic Substitution Approach, Compared with Carrier-Added ¹⁸F-DOPA, Prepared by Conventional Electrophilic Substitution
Willem-Jan Kuik, Ido P. Kema, Adrienne H. Brouwers, Rolf Zijlma, Kiel D. Neumann, Rudi A.J.O. Dierckx, Stephen G. DiMagno and Philip H. Elsinga

Journal of Nuclear Medicine January 1, 2015, 56 (1) 106-112; DOI: https://doi.org/10.2967/jnumed.114.145730
You have access
Impact of ⁶⁸Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective
Ken Herrmann, Johannes Czernin, Edward M. Wolin, Pawan Gupta, Martin Barrio, Antonio Gutierrez, Christiaan Schiepers, Sherly Mosessian, Michael E. Phelps and Martin S. Allen-Auerbach

Journal of Nuclear Medicine January 1, 2015, 56 (1) 70-75; DOI: https://doi.org/10.2967/jnumed.114.148247
You have access
Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study
Damian Wild, Melpomeni Fani, Richard Fischer, Luigi Del Pozzo, Felix Kaul, Simone Krebs, Richard Fischer, Jean E.F. Rivier, Jean Claude Reubi, Helmut R. Maecke and Wolfgang A. Weber

Journal of Nuclear Medicine August 1, 2014, 55 (8) 1248-1252; DOI: https://doi.org/10.2967/jnumed.114.138834
You have access
Prognostic Stratification of Metastatic Gastroenteropancreatic Neuroendocrine Neoplasms by ¹⁸F-FDG PET: Feasibility of a Metabolic Grading System
Samer Ezziddin, Linda Adler, Amir Sabet, Thorsten Dirk Pöppel, Florian Grabellus, Ali Yüce, Hans-Peter Fischer, Birgit Simon, Tobias Höller, Hans-Jürgen Biersack and James Nagarajah

Journal of Nuclear Medicine August 1, 2014, 55 (8) 1260-1266; DOI: https://doi.org/10.2967/jnumed.114.137166
You have access
Everolimus Reduces ⁸⁹Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
Sophie J. van Asselt, Sjoukje F. Oosting, Adrienne H. Brouwers, Alfons H.H. Bongaerts, Johan R. de Jong, Marjolijn N. Lub-de Hooge, Thijs H. Oude Munnink, Helle-Brit Fiebrich, Wim J. Sluiter, Thera P. Links, Annemiek M.E. Walenkamp and Elisabeth G.E. de Vries

Journal of Nuclear Medicine July 1, 2014, 55 (7) 1087-1092; DOI: https://doi.org/10.2967/jnumed.113.129056
You have access
Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-Octreotate
Samer Ezziddin, Mared Attassi, Charlotte J. Yong-Hing, Hojjat Ahmadzadehfar, Winfried Willinek, Frank Grünwald, Stefan Guhlke, Hans-Jürgen Biersack and Amir Sabet

Journal of Nuclear Medicine February 1, 2014, 55 (2) 183-190; DOI: https://doi.org/10.2967/jnumed.113.125336
You have access
Long-Term Outcome and Toxicity After Dose-Intensified Treatment with ¹³¹I-MIBG for Advanced Metastatic Carcinoid Tumors
Samer Ezziddin, Amir Sabet, Timur Logvinski, Khaled Alkawaldeh, Charlotte J. Yong-Hing, Hojjat Ahmadzadehfar, Frank Grünwald and Hans-Jürgen Biersack

Journal of Nuclear Medicine December 1, 2013, 54 (12) 2032-2038; DOI: https://doi.org/10.2967/jnumed.112.119313
You have access
Comparative Biodistribution and Radiation Dosimetry of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE in Patients with Neuroendocrine Tumors
Mattias Sandström, Irina Velikyan, Ulrike Garske-Román, Jens Sörensen, Barbro Eriksson, Dan Granberg, Hans Lundqvist, Anders Sundin and Mark Lubberink

Journal of Nuclear Medicine October 1, 2013, 54 (10) 1755-1759; DOI: https://doi.org/10.2967/jnumed.113.120600

Main menu

User menu

Search

neuroendocrine tumors

Pages